Table 1. The demographics of the recipients with LT.
| Parameters | All patients (n = 185) | LDLT (n = 109) | DDLT (n = 76) | P |
|---|---|---|---|---|
| Age, yr | 52.4 ± 9.6 | 52.0 ± 8.5 | 53.1 ± 11.0 | 0.488 |
| Gender (male/female) | 131/54 | 81/28 | 50/26 | 0.210 |
| Score of MELD | 17.6 ± 11.5 | 12.5 ± 8.3 | 24.9 ± 11.7 | < 0.001 |
| Child-Pugh score | 4.6 ± 3.7 | 3.6 ± 3.2 | 6.1 ± 3.9 | < 0.001 |
| Underlying liver disease | < 0.001 | |||
| HCC | 84 (45.4) | 68 (62.4) | 16 (21.1) | |
| Cause of hepatic disease | ||||
| HBV | 108 (58.4) | 78 (71.6) | 30 (39.5) | |
| HCV | 21 (11.4) | 13 (11.9) | 8 (10.5) | |
| Coinfection of HBV/HCV | 4 (2.2) | 2 (1.8) | 2 (2.6) | |
| Alcohol-related liver disease | 40 (21.6) | 19 (17.4) | 21 (30.0) | |
| Autoimmune hepatitis | 5 (2.7) | 1 (0.9) | 4 (5.3) | |
| Toxic hepatitis | 6 (3.2) | 1 (0.9) | 5 (6.6) | |
| Idiopathic hepatitis | 7 (3.8) | 1 (0.9) | 6 (7.8) | |
| Others* | 5 (2.7) | 2 (1.8) | 3 (3.9) | |
| Pre-operating laboratory finding | ||||
| ALT | 104.9 ± 318.2 | 89.1 ± 324.8 | 127.6 ± 309.3 | 0.420 |
| Cr | 1.0 ± 0.7 | 0.9 ± 0.4 | 1.2 ± 0.9 | 0.002 |
| ALP | 271.1 ± 187.4 | 240.1 ± 120.9 | 315.6 ± 248.3 | 0.016 |
| INR | 1.8 ± 0.7 | 1.5 ± 0.7 | 2.2 ± 0.7 | < 0.001 |
| PLT | 79.0 ± 49.5 | 88.4 ± 52.3 | 65.6 ± 41.9 | 0.001 |
| CRP | 1.6 ± 2.4 | 0.7 ± 1.4 | 2.9 ± 3.0 | < 0.001 |
| BNP | 184.7 ± 426.6 | 126.9 ± 279.5 | 273.3 ± 576.5 | 0.042 |
Values are presented as mean ± SD or number (%).
LT = liver transplantation, LDLT = living donor liver transplantation, DDLT = deceased donor liver transplantation, MELD = model for end-stage liver disease, HCC = hepatocellular carcinoma, HBV = hepatitis B, HCV = hepatitis C, ALT = alanine transaminase, Cr = creatinine, ALP = alkaline phosphatase, INR = international normalized ratio, PLT = platelet, CRP = C-reactive peptide, BNP = brain natriuretic peptide, SD = standard deviation.
*Others: 1 sclerosing cholangitis, 1 primary pulmonary hypertension, 1 Klatskin tumor, 2 Wilson's disease.